The need for long-term treatment in the mouse lymphoma assay
Authors:
Open Access
- 1 January 1999
- journal article
- research article
- Published by Oxford University Press (OUP) in Mutagenesis
- Vol. 14 (1) , 23-29
Abstract
The L5178Y tk+/– mouse lymphoma assay (MLA) has been widely used as a genotoxicity test for the detection of mutagens and clastogens. The standard MLA, as well as other mammalian cell gene mutation assays, usually employs a short treatment period (3–6 h). Our previous report, however, suggested that such short treatments may be insufficient for detecting some clastogens and spindle poisons. For the present study, we introduced and evaluated a longer treatment (24 h) in the MLA. We examined 15 chemicals which were evaluated as negative or inconclusive in the short-term study. Cells were exposed to the chemical for 24 h without S9 mix, cultured for 2 days and then thymidine kinase-deficient mutants were selected in 96-well microtiter plates under trifluorothymidine. Eleven chemicals yielded positive responses in the 24 h treatment MLA. They included nucleoside analogs (2′-deoxycoformycin and dideoxycytidine), a base analog (1,3-dimethylxanthine) and spindle poisons (colchicine and vinblastine sulfate), all of which do not directly affect DNA, but bring about mutations and chromosome alterations through nucleoside metabolism and chromosome segregation. Because the mutagenicities of these non-DNA targeting chemicals appear to be cell cycle dependent, treatment extending over more than one cell cycle may be required for their effect. Combining results from the present and previous studies, 31 of 34 (91%) chromosome aberration-positive chemicals exhibited positive responses in the MLA, suggesting that the sensitivity of the MLA with 24 h treatment periods approaches that of the chromosome aberration test.Keywords
This publication has 36 references indexed in Scilit:
- Consensus agreement regarding protocol issues discussed during the mouse lymphoma workshop: Portland, Oregon, may 7, 1994Environmental and Molecular Mutagenesis, 1995
- Cell-cycle dependent mutation of human lymphoblasts: Bromodeoxyuridine and butyl methanesulfonateMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Mutagenicity of 2-amino-N6-hydroxyadenine to TK6 human lymphoblast cellsMutation Research/Environmental Mutagenesis and Related Subjects, 1991
- Chemical mutagenesis at the thymidine kinase locus in L5178Y mouse lymphoma cells: Results for 31 coded compounds in the national toxicology programEnvironmental and Molecular Mutagenesis, 1991
- Responses of the L5178Y mouse lymphoma cell forward mutation assay. V: 27 coded chemicalsEnvironmental and Molecular Mutagenesis, 1991
- L5178Y mouse lymphoma cell mutation assay results with 41 compoundsEnvironmental and Molecular Mutagenesis, 1990
- The mutagenic activity of selected compounds at the TK locus: Rodent vs. human cellsMutation Research/Reviews in Genetic Toxicology, 1988
- Evaluation of the L5178Y mouse lymphoma cell mutagenesis assay: Intralaboratory results for sixty-three coded chemicals tested at litton bionetics, incEnvironmental Mutagenesis, 1988
- A comparison of the agar cloning and microtitration techniques for assaying cell survival and mutation frequency in L5178Y mouse lymphoma cellsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1983
- Mutagenic evaluation of carcinogens and non-carcinogens in the L5178Y/TK assay utilizing postmitochondrial fractions (S9) from normal rat liverMutation Research/Environmental Mutagenesis and Related Subjects, 1982